Chymase inhibitor ameliorates hepatic steatosis and fibrosis on established non-alcoholic steatohepatitis in hamsters fed a methionine- and choline-deficient diet-Reference-Cited by-同舟云学术

Chymase inhibitor ameliorates hepatic steatosis and fibrosis on established non-alcoholic steatohepatitis in hamsters fed a methionine- and choline-deficient diet

Published:2013-01-10 Issue:9 Volume:43 Page:970-978
ISSN:1386-6346
Container-title:Hepatology Research
language:en
Short-container-title:Hepatol Res

Author:

Masubuchi Shinsuke¹,Takai Shinji²,Jin Denan²,Tashiro Keitaro¹,Komeda Koji¹,Li Zhong-Lian³,Otsuki Yoshinori³,Okamura Haruki⁴,Hayashi Michihiro¹,Uchiyama Kazuhisa¹

Affiliation:

1. Department of General and Gastroenterological Surgery; Osaka Medical College; Takatsuki; Japan

2. Department of Pharmacology; Osaka Medical College; Takatsuki; Japan

3. Department of Anatomy and Cell Biology; Osaka Medical College; Takatsuki; Japan

4. Laboratory of Host Defenses; Institute for Advanced Medical Sciences; Hyogo College of Medicine; Hyogo; Japan

Publisher

Wiley

Subject

Infectious Diseases,Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/hepr.12042/fullpdf

Reference39 articles.

1. Nonalcoholic fatty liver disease;Angulo;N Engl J Med,2002

2. Nonalcoholic fatty liver disease;Clark;Gastroenterology,2002

3. Nonalcoholic steatohepatitis: Mayo Clinic experiences with a hitherto unnamed disease;Ludwig;Mayo Clin Proc,1980

4. The natural history of nonalcoholic steatohepatitis: a follow-up study of forty-two patients for up to 21 years;Powell;Hepatology,1990

5. Expanding the natural history of nonalcoholic steatohepatitis: from cryptogenic cirrhosis to hepatocellular carcinoma;Bugianesi;Gastroenterology,2002

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Biased Quantification of Rat Liver Fibrosis—Meta-Analysis with Practical Recommendations and Clinical Implications;Journal of Clinical Medicine;2023-08-01

2. Sheltered in Stromal Tissue Cells, Trypanosoma cruzi Orchestrates Inflammatory Neovascularization via Activation of the Mast Cell Chymase Pathway;Pathogens;2022-01-29

3. Mast cells in liver disease progression: An update on current studies and implications;Hepatology;2021-12-12

4. Chymase as a Possible Therapeutic Target for Amelioration of Non-Alcoholic Steatohepatitis;International Journal of Molecular Sciences;2020-10-13

5. Mechanism of Albuminuria Reduction by Chymase Inhibition in Diabetic Mice;International Journal of Molecular Sciences;2020-10-11